Insilico Medicine logo

Insilico Medicine

Insilico Medicine is a drug discovery, artificial intelligence company that looks to treat cancer and age related diseases

6

Funding Rounds

$356.3m

Money raised

Overview

Insilico Medicine is a drug discovery, artificial intelligence company that looks to treat cancer and age related diseases

Funding

Funding series

Funding Series Analysis

The company Insilico Medicine has raised a total of $352m in funding over 6 rounds.

Key Insights:

  • Insilico Medicine Series D round, June 2022: $60m
  • Insilico Medicine Series C round, June 2021: $255m
  • Insilico Medicine funding round, September 2019: $37m
  • Insilico Medicine Series A round, February 2017: $2.8m
  • Insilico Medicine Convertible note, November 2014: $1.2m
  • Insilico Medicine Seed round, April 2014: $300k
Insilico Medicine logo
Insilico Medicine Series D round, June 2022 $60m
Insilico Medicine logo
Insilico Medicine Series C round, June 2021 $255m
Insilico Medicine logo
Insilico Medicine funding round, September 2019 $37m
Insilico Medicine logo
Insilico Medicine Series A round, February 2017 $2.8m
Insilico Medicine logo
Insilico Medicine Convertible note, November 2014 $1.2m
Insilico Medicine logo
Insilico Medicine Seed round, April 2014 $300k

Industries

Insilico Medicine is active in the following industries:
  • Technology
  • Drug discovery
  • Chemistry
  • Therapeutics
  • Artificial Intelligence (AI)
  • Engineering
  • Biomedical engineering
  • Drug development
  • Machine learning
  • Biology
  • Biopharmaceutical
  • Diagnosis
  • Pharmaceutical industry
  • Biotechnology
  • Anti-Aging
  • Bioinformatics